We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$63.1B
AUM Growth
+$3.79B
Cap. Flow
-$1.12B
Cap. Flow %
-1.77%
Top 10 Hldgs %
32.11%
Holding
999
New
156
Increased
303
Reduced
370
Closed
127

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$1.35B
2
INSM icon
Insmed
INSM
+$197M
3
HUBB icon
Hubbell
HUBB
+$191M
4
ARGX icon
argenx
ARGX
+$164M
5
SLNO
Soleno Therapeutics
SLNO
+$161M

Sector Composition

Rank Sector Weight
1 Technology 30.31%
2 Healthcare 13.97%
3 Financials 11.89%
4 Consumer Discretionary 9.55%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUE icon
376
Nucor
NUE
$61.9B
$28.3M 0.04%
209,000
+87,700
+72% +$12.4M
IBKR icon
377
Interactive Brokers
IBKR
$38.8B
$27.9M 0.04%
+405,300
New +$25.5M
MOS icon
378
The Mosaic Company
MOS
$7.46B
$27.9M 0.04%
803,920
+53,400
+7% +$1.84M
HCA icon
379
HCA Healthcare
HCA
$88.5B
$27.8M 0.04%
65,276
-68,824
-51% -$26.7M
BXP icon
380
Boston Properties
BXP
$11B
$27.8M 0.04%
373,918
-32,569
-8% -$2.3M
DELL icon
381
Dell
DELL
$283B
$27.8M 0.04%
196,000
+16,600
+9% +$2.15M
BNTC icon
382
Benitec Biopharma
BNTC
$451M
$27.7M 0.04%
1,972,524
RPM icon
383
RPM International
RPM
$14.8B
$27.1M 0.04%
230,000
+105,000
+84% +$12.6M
VRSK icon
384
Verisk Analytics
VRSK
$24.7B
$27M 0.04%
107,400
+21,100
+24% +$5.79M
NVS icon
385
Novartis
NVS
$293B
$27M 0.04%
210,188
+195,707
+1,351% +$23.9M
ODFL icon
386
Old Dominion Freight Line
ODFL
$43.8B
$26.9M 0.04%
190,787
+65,487
+52% +$10M
GTLS
387
DELISTED
Chart Industries
GTLS
$26.7M 0.04%
+133,603
New +$25.4M
EME icon
388
Emcor
EME
$35.7B
$26.4M 0.04%
+40,700
New +$24.7M
VRDN icon
389
Viridian Therapeutics
VRDN
$2.55B
$26.3M 0.04%
1,220,128
+111,542
+10% +$2.01M
DOCU
390
DocuSign
DOCU
$10.9B
$26.3M 0.04%
365,000
+75,000
+26% +$5.78M
IQV icon
391
IQVIA
IQV
$38.3B
$26.3M 0.04%
138,300
+101,868
+280% +$18.5M
DD icon
392
DuPont de Nemours
DD
$19.5B
$26.2M 0.04%
267,840
-37,523
-12% -$3.54M
AMCR icon
393
Amcor
AMCR
$21.8B
$26.2M 0.04%
639,801
-99,937
-14% -$4.48M
BMY icon
394
Bristol-Myers Squibb
BMY
$131B
$26.2M 0.04%
580,061
+384,097
+196% +$17.9M
ADM icon
395
Archer Daniels Midland
ADM
$37.4B
$26.1M 0.04%
437,392
-2,700
-0.6% -$158K
YUM icon
396
Yum! Brands
YUM
$41.6B
$26.1M 0.04%
171,702
-82,900
-33% -$12.2M
WAY
397
Waystar Holding Corp
WAY
$4.48B
$25.9M 0.04%
684,234
+580,234
+558% +$21.5M
AEE icon
398
Ameren
AEE
$30B
$25.7M 0.04%
+246,190
New +$24.6M
MIAX
399
Miami International Holdings
MIAX
$4.4B
$25.4M 0.04%
+631,652
New +$23.1M
XYL icon
400
Xylem
XYL
$28.2B
$25.3M 0.04%
171,593
-326,300
-66% -$45.3M

Similar funds

Adage Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Adage Capital Partners held 999 positions worth $63.1B, up 6.4% from $59.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q3 2025 filing shows 156 new, 303 increased, 370 reduced and 127 closed positions. Its largest new stake was Chevron: 3,284,841 shares worth $510M. The largest sale was Hess, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2025 buy was Chevron: 3,284,841 shares worth $510M.
  • Adage Capital Partners added most to Royalty Pharma in Q3 2025, an estimated $216M increase.
  • Adage Capital Partners's biggest Q3 2025 reduction was Insmed, cutting an estimated $197M.
  • Adage Capital Partners fully exited Hess in Q3 2025, selling an estimated $1.35B.
  • Adage Capital Partners's ten largest holdings make up 32% of its $63.1B portfolio in Q3 2025.
  • Adage Capital Partners opened 156 new positions and closed 127 in Q3 2025.
  • Adage Capital Partners's portfolio value rose 6.4% quarter-over-quarter to $63.1B.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.